NDC Compounded Drug 72907-1821-3 Betamethasone Sodium Phosphate
Injection Epidural; Intra-articular; Intrabursal; Intramuscular
Compounded Drug Product Information
NDC Crossover Products Matching Betamethasone Sodium Phosphate
NDC crossover of Betamethasone Sodium Phosphate with NDC 72907-1821 a human compounded drug with other similar products matching the same substance name (Betamethasone Sodium Phosphate) and the same administration route (epidural; intra-articular; intrabursal; intramuscular) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
71266-1015-1 | Betamethasone Sodium Phosphate | Betamethasone Sodium Phosphate | 1 mL in 1 VIAL | Injection | Epidural | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
71266-1015-2 | Betamethasone Sodium Phosphate | Betamethasone Sodium Phosphate | 2 mL in 1 VIAL | Injection | Epidural | Fagron Compounding Services Llc Dba Fagron Sterile Services Llc Dba Jcb Laboratories |
Frequently Asked Questions
What is the NDC number assigned to Betamethasone Sodium Phosphate?
Betamethasone Sodium Phosphate was assigned by its manufacturer with NDC product code 72907-1821. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Betamethasone Sodium Phosphate?
The NDC package code 72907-1821-3 was assigned to a 3 mL in 1 VIAL, SINGLE-USE of betamethasone sodium phosphate administered epidural; intra-articular; intrabursal; intramuscular via injection.
Who manufactures this product?
Betamethasone Sodium Phosphate is manufactured by an outsourced facility and labeled by Brookfield Medical Surgical Supply. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories with NDC product codes 71266-1015-1 and 71266-1015-2.